Hence, we hypothesized that SQOR may activate the interaction network between NK T cells and Gamma belta T cells, thereby increasing the abundance of immune cell infiltration, altering the tumor microenvironment, and enhancing the patient’s response to immunotherapy. The gene discussed is SQOR; the disease is neoplasm.